• About
  • Licensing
  • Podcasting
  • Contact

AudioMedica.com

Medical News Interviews

  • Public Health
  • Oncology
  • Cardiovascular
  • General Medicine

TAXUS DES Trials Results: How Long Should Thienopyridine Be Used After Drug Eluting Stent?

0
  • by alexperjescuadmin
  • in Cardiovascular
  • — 6 Nov, 2007
TAXUS DES Trials Results: How Long Should Thienopyridine Be Used After Drug Eluting Stent?
AudioMedica News
TAXUS DES Trials Results: How Long Should Thienopyridine Be Used After Drug Eluting Stent?
TAXUS DES Trials Results: How Long Should Thienopyridine Be Used After Drug Eluting Stent?
00:00 /
RSS Feed
Share
Link
Embed
Gregg Stone
Gregg Stone
REFERENCE: Abstract 2357, American Heart Association Scientific Sessions, 4-7 November, 2007, Orlando, Florida
GREGG STONE, Columbia University, New York
New light has been thrown on the use of thienopyridine therapy after percutaneous intervention using drug-eluting stents. Gregg Stone presented data from the TAXUS DES trials which looked at patients surviving more than a year after receiving either paclitaxel-eluting or bare metal stents. After his talk at the American Heart Association he discussed his findings with Sarah Maxwell.

[audio:https://www.audiomedica.com/podcasting/cardio/071106GreggStonePODCAST.mp3]
Share

Tags: cardiovasculardrug-elutinggregg stoneheartstentstentingstentstherapytrial

You may also like...

  • Audio Journal of Cardiovascular Medicine 10.3, May 2004 Audio Journal of Cardiovascular Medicine 10.3, May 2004 8 Jan, 2006
  • Audio Journal of Cardiovascular Medicine: September 3rd 2006 Audio Journal of Cardiovascular Medicine: September 3rd 2006 3 Sep, 2006
  • Competitive and Leisure Sports: Recommendations to Minimise Cardiovascular Risk Competitive and Leisure Sports: Recommendations to Minimise Cardiovascular Risk 28 Aug, 2016
  • Audio Journal of Cardiovascular Medicine: “EXACT” Study: Carotid Stenting Benefits Are Maintained in the Real World Audio Journal of Cardiovascular Medicine: “EXACT” Study: Carotid Stenting Benefits Are Maintained in the Real World 27 Mar, 2007

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

  • Previous story Torcetrapib in Patients at High Risk for Coronary Events: ILLUMINATE Trial Latest Results
  • Next story Oral Contraceptive Use: More Carotid and Femoral Atheroschlerosis Later in Life
  • News

    • Mandeep Mehra MDCOVID-19 Co-Morbidity Risks Quantified from Three Continents SurveyMay 28, 2020
    • Ultrahypofractionated Radiation Just As Effective for Prostate CancerUltrahypofractionated Radiation Just As Effective for Prostate CancerMay 16, 2018
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer riskMarch 6, 2014
  • Related interviews

    • Ibrutinib: New Frontline Standard for Chronic…
    • Microbiome Diversity Key To Survival After…
    • Genomic-led AML Clinical Decision Making Within Seven Days
    • First Line PARP Inhibition For Ovarian Cancer Assessed
    • New Front Line Standard for Older Patients with…
  • Home
  • Cardiovascular
  • TAXUS DES Trials Results: How Long Should Thienopyridine Be Used After Drug Eluting Stent?

© Copyright 2021 AudioMedica.com. Typegrid Theme by WPBandit.